ScholarMate
English简体中文繁體中文
客服熱線:400-1616-289
登入註冊
期刊論文

Ferroptosis induction via targeting metabolic alterations in triple-negative breast cancer

Wang, Yaru; Sun, Yue; Wang, Feiran; Wang, Hongyi; Hu, Jing*哈尔滨医科大学
Biomedicine and Pharmacotherapy2023-12-31DOI: 10.1016/j.biopha.2023.115866
10閱讀
引用收藏
分享

摘要

Triple-negative breast cancer (TNBC), the most aggressive form of breast cancer, presents severe threats to women's health. Therefore, it is critical to find novel treatment approaches. Ferroptosis, a newly identified form of programmed cell death, is marked by the buildup of lipid reactive oxygen species (ROS) and high iron concentrations. According to previous studies, ferroptosis sensitivity can be controlled by a number of metabolic events in cells, such as amino acid metabolism, iron metabolism, and lipid metabolism. Given that TNBC tumors are rich in iron and lipids, inducing ferroptosis in these tumors is a potential approach for TNBC treatment. Notably, the metabolic adaptability of cancer cells allows them to coordinate an attack on one or more metabolic pathways to initiate ferroptosis, offering a novel perspective to improve the high drug resistance and clinical therapy of TNBC. However, a clear picture of ferroptosis in TNBC still needs to be completely revealed. In this review, we provide an overview of recent advancements regarding the connection between ferroptosis and amino acid, iron, and lipid metabolism in TNBC. We also discuss the probable significance of ferroptosis as an inno-vative target for chemotherapy, radiotherapy, immunotherapy, nanotherapy and natural product therapy in TNBC, highlighting its therapeutic potential and application prospects.

學科與關鍵詞

關鍵詞
Triple -negative breast cancer (TNBC)FerroptosisMetabolic reprogrammingTherapy
相關
載入中…
  • Integrated profiling uncovers prognostic, immunological, and pharmacogenomic features of ferroptosis in triple-negative breast cancer
    Fang, Kun*; Xu, Zhengjie; Jiang, Suxiao; Yan, Changsheng; Tang, Desheng; Huang, YanFrontiers in Immunology, 2022, 13: 985861.被引 1
  • Emerging role of ferroptosis in breast cancer: New dawn for overcoming tumor progression
    Sui, Shiyao; Xu, Shouping*; Pang, Da*Pharmacology and Therapeutics, 2022, 232: 107992.被引 51
  • Ferroptosis: The Silver Lining of Cancer Therapy
    Tang, Zhengming; Huang, Zhijie; Huang, Yisheng; Chen, Yuanxin; Huang, Mingshu; Liu, Hongyu; Ye, Q. Adam*; Zhao, Jianjiang*; Jia, Bo*Frontiers in Cell and Developmental Biology, 2021, 9: 765859.被引 27
查看全部 →

發表資訊

論文狀態
公開發表
期刊
Biomedicine and Pharmacotherapy
發表日期
2023-12-31
卷期
第 169 卷
頁碼
115866
DOI
10.1016/j.biopha.2023.115866
語言
MULTI-LANGUAGE
成果收錄
SCIE
資助標註
National Natural Science Foundation of China [81972162]; Natural Science Fund for Outstanding Youth of Heilongjiang Province [YQ2019H026]; Postdoctoral Scientific Research Staring Fund of Heilongjiang Province [LBH-Q19042]; Outstanding Youth Fund Project of Harbin Medical University Cancer Hospital [JCQN2020-01]

作者

  • W

    Wang, Yaru (第一作者)

    harbin med univ

  • S

    Sun, Yue

    harbin med univ

查看全部 5 位作者收起作者
  • W

    Wang, Feiran

    harbin med univ

  • W

    Wang, Hongyi

    harbin med univ

  • H

    Hu, Jing (通訊)

    harbin med univ

登入解鎖更多功能

  • 收藏這篇,隨時在「我的 · 收藏」找回
  • 認領你的成果,生成推廣素材
  • 關注作者獲取最新成果
  • 加入項目組、協同寫作
註冊 / 登入

產品服務

  • 科研之友
  • 創新城
  • 科創雲

服務支援

  • 幫助中心
  • 隱私政策
  • 服務條款

聯絡方式

線上客服:【】
客服熱線:400-1616-289
電子郵件:support@scholarmate.com

關注或下載科研之友

微信 QR Code
微信公眾號
客戶端下載 QR Code
下載客戶端
科研成果科研人員科研機構科研動態愛瑞思軟件

©2026 深圳市科研之友网络服务有限公司

公安備案圖示粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417